XML 20 R6.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities:    
Net loss $ (61,376) $ (8,943)
Adjustments to reconcile net loss to net cash (used for) provided by operating activities:    
Depreciation and amortization 3,186 3,750
Change in fair value of warrant 5,278 1,123
Share-based compensation 29,940 0
Asset retirement obligation accretion 130 122
Amortization of intangible 50 51
Amortization of debt issuance costs and discounts 1,696 1,860
Non-cash interest expense 0 33
Bad debt provision 3  
Bad debt (recovery) 0 (53)
Other, net 104 0
Changes in operating assets and liabilities:    
Trade receivables and other receivables (409) 4,691
Inventories, net (1,427) (1,128)
Prepaid expenses and other current assets (1,140) (171)
Accounts payable 11,319 2,943
Accrued expenses 281 1,001
Deferred revenue (626) 545
Net cash (used for) provided by operating activities (12,991) 5,824
Cash flows from investing activities:    
Capital expenditures (1,824) (2,068)
Net cash (used for) investing activities (1,824) (2,068)
Cash flows from financing activities:    
Proceeds from initial offering of common stock 68,714 0
Proceeds from warrant exercise 116 24
Proceeds from issuance of debt 0 5,000
Payments for deferred financing costs (4,768) (610)
Payments for taxes on share-based compensation (6,027) 0
Net cash provided by financing activities 58,035 4,414
Net increase in cash and cash equivalents 43,220 8,170
Cash and cash equivalents:    
Beginning of period 17,379 9,209
End of period 60,599 17,379
Supplemental disclosures of cash flow information:    
Cash payments for interest 6,049 5,814
Net increase in capital expenditures included in accounts payable and accrued expenses: 104 20
Net (decrease) increase in offering costs included in accounts payable and accrued expenses (588) 588
Accrued Series A-2 and A-3 preferred dividends 0 2,480
Accrued withholding tax for share based compensation 2,515 0
Deferred financing costs charged to additional paid in capital 5,232 0
Noncash component of warrants exercised $ 12,591 $ 0